Inhibition of frusemide-induced hyperreninaemia by growth-hormone release-inhibiting hormone in man
- PMID: 56589
- DOI: 10.1016/s0140-6736(76)91611-1
Inhibition of frusemide-induced hyperreninaemia by growth-hormone release-inhibiting hormone in man
Abstract
In a study of the effect of somatostatin (growth-hormone release-inhibiting hormone) on plasma-renin in healthy volunteers, plasma-renin activity was measured by radioimmunoassay after the intravenous administration of somatostatin and also during frusemide-induced hyperreninaemia. While somatostatin was being given, basal values of renin were unchanged. Injection of frusemide alone produced hyperreninaemia; but, under somatostatin, renin release was inhibited by 45%. The results indicate that somatostatin is a potent inhibitor of renin and exerts its effect independent of sodium excretion, which was unchanged under somatostatin. Conceivably, somatostatin plays an important role in the regulation of endogenous renin release.
Similar articles
-
Actions of growth hormone-release inhibiting hormone (somatostatin) on the renin aldosterone system.J Clin Endocrinol Metab. 1976 Jul;43(1):240-3. doi: 10.1210/jcem-43-1-240. J Clin Endocrinol Metab. 1976. PMID: 947943
-
Effects of synthetic somatostatin on endotoxin-induced changes of growth hormone, cortisol and insulin in plasma, blood sugar and blood leukocytes in man.Klin Wochenschr. 1975 Jun 1;53(11):539-41. doi: 10.1007/BF01468760. Klin Wochenschr. 1975. PMID: 1152345
-
A comparison of the effects of ibuprofen and indomethacin upon renal haemodynamics and electrolyte excretion in the presence and absence of frusemide.Br J Clin Pharmacol. 1989 Apr;27(4):483-90. doi: 10.1111/j.1365-2125.1989.tb05397.x. Br J Clin Pharmacol. 1989. PMID: 2655691 Free PMC article. Clinical Trial.
-
Prevention by somatostatin of rise in blood pressure and plasma renin mediated by beta-receptor stimulation.Clin Endocrinol (Oxf). 1977 Jun;6(6):455-62. doi: 10.1111/j.1365-2265.1977.tb03329.x. Clin Endocrinol (Oxf). 1977. PMID: 884878
-
[Effect of somatostatin on kidney function].Orv Hetil. 1991 Sep 15;132(37):2033-4, 2037-9. Orv Hetil. 1991. PMID: 1681489 Review. Hungarian.
Cited by
-
Systemic hemodynamic and renal effects of midodrine and octreotide in cirrhotic patients with ascites.J Res Med Sci. 2011 Dec;16(12):1636-7. J Res Med Sci. 2011. PMID: 22973377 Free PMC article. No abstract available.
-
Hemodynamic effects of somatostatin in insulin-dependent diabetic subjects.Acta Diabetol Lat. 1979 Oct-Dec;16(4):331-7. doi: 10.1007/BF02587654. Acta Diabetol Lat. 1979. PMID: 45064 Clinical Trial.
-
Inhibitory effect of somatostatin on the aldosterone response to angiotensin II: in vitro studies.J Endocrinol Invest. 1982 May-Jun;5(3):173-7. doi: 10.1007/BF03349475. J Endocrinol Invest. 1982. PMID: 6125538
-
Sequential changes in plasma renin activity and plasma catecholamines in mildly hypertensive patients during acute, furosemide-induced body-fluid loss.Eur J Clin Pharmacol. 1983;25(3):299-302. doi: 10.1007/BF01037937. Eur J Clin Pharmacol. 1983. PMID: 6354727
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources